US2005080238A1PendingUtilityA1
Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
Priority: Oct 19, 2001Filed: Oct 4, 2004Published: Apr 14, 2005
Est. expiryOct 19, 2021(expired)· nominal 20-yr term from priority
C07K 16/065
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The method for immune serum globulin purification relates to the purification of immune globulins from blood plasma with a high degree of efficiency and a high rate of recovery. The immune globulin source is Cohn's fraction I+II+III or II+III prepared from plasma or plasma intermediates by precipitation of the paste at pH 5.7 to 5.8 in the presence of 20% ethanol and 80% purified water. A glycine extraction is followed by an anion exchange chromatography column step to achieve a significantly high yield and high purity of the concentrated protein.
Claims
exact text as granted — not AI-modified1 - 37 . (canceled)
38 . A method for producing a high yield of purified immune globulins, comprising:
suspending immune globulins in an ethanol solution; adjusting the pH of the suspension to about 5.7 to 5.8; incubating the suspension for at least two hours; adding a solution of glycine, ethanol and water to the suspension; adjusting the pH of the suspension to about 5.2 to 5.4; extracting the immune globulins from the suspension in a liquid phase to provide an extract containing immune globulins; concentrating the extract containing immune globulins, and removing any impurities from the extract containing immune globulins using an anion exchange chromatography column to provide a purified extract solution containing immune globulins; concentrating the purified extract solution containing immune globulins to provide a concentrated purified extract solution containing immune globulins; treating the concentrated purified extract solution containing immune globulins with a solvent-detergent mixture to inactivate viruses, and removing the solvent-detergent mixture from the concentrated purified extract solution containing immune globulins; and formulating the concentrated purified extract solution containing immune globulins for final use.
39 . The method of claim 38 , wherein the ethanol solution is comprised of about 19% ethanol and about 81% purified water.
40 . The method of claim 38 , wherein the step of suspending the immune globulins in the ethanol solution occurs at a temperature of about −5° C.
41 . The method of claim 38 , wherein the step of adding the solution of glycine, ethanol and water to the suspension comprises producing a final concentration of glycine in the suspension of about 0.8M and a final concentration of ethanol in the suspension of about 15% (volume/volume).
42 . The method of claim 38 , wherein the step of extracting the immune globulins from the suspension is performed by one of centrifugation and filtration.
43 . The method of claim 38 , wherein the step of extracting the immune globulins from the suspension is performed by use of a filter press.
44 . The method of claim 38 , wherein the step of extracting the immune globulins from the suspension is facilitated using diatomaceous earth at a concentration of about 1% to about 3% weight by volume during filtration.
45 . The method of claim 38 , wherein the extract containing immune globulins is concentrated through an ultrafiltration membrane.
46 . The method of claim 38 , wherein the purified extract solution containing immune globulins is concentrated using an ultrafiltration membrane.
47 . The method of claim 38 , wherein the concentrated purified extract solution containing immune globulins is formulated for final use in one of a liquid and a freeze-dried preparation.Join the waitlist — get patent alerts
Track US2005080238A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.